Sydney Tang The University of Hong KongHong Kong, China

Sydney Tang
Sydney Tang is currently Chair of Renal Medicine and Yu Professor in Nephrology at The University of Hong Kong. He graduated from HKU with MBBS and subsequently MD and PhD degrees. He trained in Nephrology at Queen Mary Hospital and in basic sciences at King’s College London, UK and the University of Washington, USA. His research interests are in pathogenetic mechanisms of diabetic and proteinuric kidney disease, and the treatment of IgA nephropathy. He has over 300 SCI publications and has contributed over 30 book chapters including one on diabetic kidney disease in Comprehensive Clinical Nephrology. He is Theme Editor in DKD for NDT, and on the Editorial Boards of KI, CJASN, American Journal of Nephrology and Kidney Diseases and the immediate past Editor-in-Chief of Nephrology (Carlton). He is the President of the Asian Pacific Society of Nephrology, Executive Committee of KDIGO, Chair of the CME Advisory Committee of the ISN and an International Honorary Member of the Japanese Society of Nephrology. He is the immediate past chairman of the Hong Kong Society of Nephrology and serves the Hong Kong College of Physicians as Council Member (co-opt) and Secretary and Program Director (HK Island) of the Specialty Board in Nephrology.

1 APRIL 2023

Time Session
14:15
15:15
Liz Lightstone Chairperson Imperial College London and Hammersmith HospitalUnited Kingdom
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • STOP-ACEi Study
    Sunil Bhandari Speaker Hull & East Yorkshire Hospitals NHS Trust United Kingdom
  • Q and A
  • DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL
    Natalie Staplin Free Communication University of OxfordUnited Kingdom
  • Q and A
  • SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN): INTERIM RESULTS OF THE PROTECT STUDY
    Muh Geot Wong Speaker University of SydneyAustralia
  • Q and A
  • RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
    Jianwen YU Free Communication The First Affiliated Hospital of Sun Yat-sen UniversityChina
  • Q and A
Plenary Halls 2 & 3

29 MARCH 2023

Time Session
15:00
16:05
Yogeshni Chandra Chairperson Lautoka HospitalFiji
  • Towards Sustainable Kidney Care and Community
    Rathika Krishnasamy Speaker Sunshine Coast University HospitalAustralia
  • Challenges and Opportunties in the Transition of Pediatric to Adult Renal Care
    Eric Aragon Speaker ericmd99@gmail.comUniveristy of the Philippines-Philippine General HospitalPhilippines
  • Nephrotic Syndrome in Cambodian Children
    Pichthida Thim Speaker Cambodian Association of NephrologyCambodia
  • Q and A
  • Closing Remarks
    Surasak Kantachuvesiri Speaker surasak.kan@mahidol.ac.thNephrology DivisionThailand
    Sydney Tang Speaker The University of Hong KongHong Kong, China
Virtual

30 MARCH 2023

Time Session
08:30
10:30
Dwomoa Adu Chairperson dwoms@blueyonder.co.ukGhana
Antonello Pani Chairperson antonello.pani@unica.itFull Professor and Director Renal UnitItaly
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • Preeclampsia and Its Possible Role in Subsequent CKD
    Vesna Garovic Speaker Mayo Clinic United States
  • Genetics and CKD
    Anna Koettgen Speaker Germany
  • APOL1 Nephropathy
    Dwomoa Adu Speaker dwoms@blueyonder.co.ukGhana
  • Q and A
MR 111
09:20
10:40
Dr Muhammad Iqbal Abdul Hafidz Chairperson Universiti Teknologi MARAMalaysia
Maria Carlota Gonzalez Bedat Chairperson ISN, UruguayUruguay
  • Regional Roundtable: Comparing and Contrasting Access to Kidney Care for Populations - Indonesia
    Yot Teerawattananon Speaker HITAPThailand
  • Regional Roundtable: Comparing and Contrasting Access to Kidney Care for Populations - Regional Perspective
    Sydney Tang Speaker The University of Hong KongHong Kong, China
  • Regional Roundtable: Comparing and Contrasting Access to Kidney Care for Populations - Bangladesh
    Shubharthi Kar Speaker Sylhet M A G Osmani Medical CollegeBangladesh
  • Regional Roundtable: Comparing and Contrasting Access to Kidney Care for Populations - ASEAN Registries
    Vuddhidej Ophascharoensuk Speaker Chiang Mai UniversityThailand
  • Regional Challenges and Successes in Preparing for the Unexpected: Natural and Man-made Disasters - Emergency Preparedness for Disaster Preparedness and Environmental Disasters
    Adrian Liew Speaker draliew2@gmail.comMount Elizabeth Novena HospitalSingapore
  • Regional Challenges and Successes in Preparing for the Unexpected: Natural and Man-made Disasters - The Need for Policies to Protect Vulnerable Populations (Focus on Migrant Workers Returning Home With AKI/ CKD)
    Sanjib Kumar Sharma Speaker B P Koirala Insttiute of Health sciencesNepal
  • Panel Discussion
MR 211 ABC
11:00
13:00
Dwomoa Adu Chairperson dwoms@blueyonder.co.ukGhana
Antonello Pani Chairperson antonello.pani@unica.itFull Professor and Director Renal UnitItaly
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • SGLT2 Inhibitors for DKD and CKD
    Sydney Tang Speaker The University of Hong KongHong Kong, China
  • Kidney Transplantation in Children
    Yuko Hamasaki Speaker Toho University Faculty of MedicineJapan
  • AKI in the Tropics and Beyond
    Nattachai Srisawat Speaker drnattachai@yahoo.comChulalongkorn University, King Chulalongkorn Memorial HospitalThailand
  • Q and A
MR 111
14:00
16:00
Dwomoa Adu Chairperson dwoms@blueyonder.co.ukGhana
Antonello Pani Chairperson antonello.pani@unica.itFull Professor and Director Renal UnitItaly
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • IgA Nephropathy: Epidemiology, Pathology, Clinical Features, Diagnosis, and Treatment of IgAN in China
    Hong Zhang Speaker Peking University First HospitalChina
  • New Antigens and Serology Based Approach in Membranous Nephropathy
    Pierre Ronco Speaker Hôpital TenonFrance
  • Kidney Size: Interaction with CKD Risk Factors in the Sardinian Population
    Antonello Pani Speaker antonello.pani@unica.itFull Professor and Director Renal UnitItaly
  • Q and A
MR 111

31 MARCH 2023

Time Session
14:15
15:15
Hyeong Cheon Park Chairperson Gangnam Severance Hospital, Yonsei University College of MedicineSouth Korea
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • President APSN - Introduction of Kenzo Oshima Award
    Sydney Tang Speaker The University of Hong KongHong Kong, China
  • Kenzo Oshima Award
    David Harris Speaker University of SydneyAustralia
  • President APSN - Introduction of Excellence in Basic Science Award
    Sydney Tang Speaker The University of Hong KongHong Kong, China
  • Excellence in Basic Science Award
    Ming LI Speaker Guangdong Provincial People's HospitalChina
  • President APSN - Introduction of Haiyan Wang Lecture
    Sydney Tang Speaker The University of Hong KongHong Kong, China
  • Haiyan Wang Lecture
    Somchai Eiam Ong Speaker Chulalongkorn Memorial Hospital Thailand
MR 110
17:00
18:00
  • Acute Kidney Injury – Mechanisms, Experimental Models and Biomarkers
    Letizia De Chiara Moderator letizia.dechiara@unifi.itUniversità degli studi di FirenzeItaly
  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 1
    Chirag Parikh Moderator chirag.parikh@jhmi.eduJohns Hopkins UniversityUnited States
  • Bioethics, Supportive/Palliative Care and Quality of Life in Kidney Failure
    Marques Ng Moderator The Chinese University of Hong KongHong Kong, China
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 1
    Chuan-Ming Hao Moderator Huashan Hospital Fudan UniversityChina
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 2
    Vivek Kumar Moderator PGIMER, ChandigarhIndia
  • Chronic Kidney Disease Diagnosis, Classification and Progression 1
    Sydney Tang Moderator The University of Hong KongHong Kong, China
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 1
    Matthias Kretzler Moderator kretzler@umich.eduUniversity Of Michigan Medical CenterUnited States
  • Clinical Glomerulonephritis 1
  • Clinical Glomerulonephritis 2
    Warangkana Pichaiwong Moderator Rajavithi HospitalThailand
  • Covid-19 and AKI
    Neil Boudville Moderator Sir Charles Gairdner HospitalAustralia
  • Covid-19 and KF (Kidney Failure)
    Sarinya Boongird Moderator Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol UniversityThailand
  • Diabetic Kidney Disease, Drugs and Treatments 1
    John Cijiang He Moderator United States
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 1
    Abduzhappar Gaipov Moderator Nazarbayev University School of MedicineKazakhstan
  • Epidemiology, Outcomes and Health Services Research in Dialysis 1
    Geraldo Bezerra da Silva Jr Moderator University of FortalezaBrazil
  • Experimental Models- Glomerulonephritis
  • Haemodialysis, Haemodiafiltration and Vascular Access 1
    Anil Agarwal Moderator akagarwalmd@gmail.comUniversity of California San Francisco at Fresno and VA Central California Health Care SystemUnited States
  • Kidney in Pregnancy and Post-Partum
    Liz Lightstone Moderator Imperial College London and Hammersmith HospitalUnited Kingdom
  • Kidney Transplantation and Transplant Immunology 1
    Eric Rondeau Moderator Sorbonne Université Hopital TenonFrance
  • Kidney Transplantation and Transplant Immunology 2
    Ahmed Kalebi Moderator Ahmed Kalebi ConsultancyKenya
  • Online Learning
    Amnart Chaiprasert Moderator Thailand
  • Other AKI
    Watanyu Parapiboon Moderator Maharat Nakhonratchasima HospitalThailand
  • Other CKD 1
    Juliana Chan Moderator The Chinese University of Hong KongHong Kong, China
  • Peritoneal Dialysis 1
    Xueqing Yu Moderator Guangdong Provincial People's HospitalChina
  • Social Media
    Sibel Bek Moderator Kocaeli University HospitalTurkey
  • Special Challenges in the Burden and Management of CKD in Developing Countries
    Kearkiat Praditpornsilpa Moderator kearkiat@hotmail.comThailand
Ballroom 2-3-4-Exhibition Hall

INDUSTRY SYMPOSIA PROGRAM (FRIDAY, MARCH 31, 2023)

Time Session
13:00
14:00
Organized by Science Collected. Supported by an unrestricted educational grant from AstraZeneca
Carol Pollock Chairperson University of SydneyAustralia
  • Welcome and Introductions
    Carol Pollock Speaker University of SydneyAustralia
  • Three-pronged protection – mortality, cardiovascular, and kidney benefits with SGLT2 inhibitors
    Sydney Tang Speaker The University of Hong KongHong Kong, China
  • Old problems, new solutions – practical approaches to optimising care
    Carol Pollock Speaker University of SydneyAustralia
  • Is it too late? An opportunity to intervene early
    Mustafa Arici Speaker
  • Panel discussion and Q and A
  • Closing remarks
    Carol Pollock Speaker University of SydneyAustralia
MR 109 CDHG